Astrana Health (ASTH) Non-Current Receivables (2016 - 2026)

Astrana Health's Non-Current Receivables history runs 11 years deep, the most recent figure standing at $49.1 million for Q1 2026.

• In Q1 2026, Non-Current Receivables rose 1.94% year-over-year to $49.1 million; the TTM figure through Mar 2026 stood at $49.1 million (up 1.94% YoY), while the FY2025 annual figure was $48.7 million, up 205.61% from the prior year.
• Non-Current Receivables came in at $49.1 million for Q1 2026 at Astrana Health, up from $48.7 million in the prior quarter.
• In the past five years, Non-Current Receivables ranged from a high of $49.1 million in Q1 2026 to a low of $15.9 million in Q1 2022.
• A 5-year average of $24.2 million and a median of $15.9 million in 2022 frame the typical range for Non-Current Receivables.
• Across the five-year window, Non-Current Receivables surged 2701.93% in 2022 and plunged 39.78% in 2024, its largest moves.
• Astrana Health's Non-Current Receivables stood at $15.9 million in 2022, then surged by 66.05% to $26.5 million in 2023, then slumped by 39.78% to $15.9 million in 2024, then soared by 205.61% to $48.7 million in 2025, then climbed by 0.71% to $49.1 million in 2026.
• According to Business Quant data, Non-Current Receivables over the past three periods registered $49.1 million, $48.7 million, and $48.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison